Posters & Publications

Third Quarter 2026 Earnings Conference Call  Click Here

To view our PMN310 Scientific and Clinical Update (November 2026)   Click Here

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

PMN310 | Amyloid-Beta

PMN310 Poster AAIC 2026

View
PMN440 | A-Syn Vaccine

Vaccination with Conformational Epitopes Derived from Computational Modeling Elicits Active Antibody Response Selective for Toxic Alpha-Synuclein Species

View
PMN267 | TDP-43

Rational Design of a Vaccine Against TDP-43 Proteinopathies Using a Pathogenic Epitope of Misfolded TDP-43

View
PMN310 | Amyloid-Beta

Relationship between efficacy and preferential targeting of soluble Aβ aggregates

View
PMN310 | Amyloid-Beta

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer’s disease

View
EpiSelect™ Platform

Protein misfolding-specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

View
PMN310 | Amyloid-Beta

PRECISE-AD, A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's Disease

View
PMN310 | Amyloid-Beta

Leveraging recent advances in biomarkers to optimize early phase drug development in Alzheimer’s Disease

View
EpiSelect™ Platform

Prediction of Misfolding-Specific Epitopes in SOD1 Using EpiSelect™ (platform formerly called Collective Coordinates)

View
PMN267 | TDP-43

Rational Generation of Monoclonal Antibodies and Intrabodies Selective for Pathogenic TDP-43

View
PMN311 | AD Vaccine

Alzheimer's Disease Vaccine Presentation

View
PMN311 | AD Vaccine

Narration of Alzheimer's Disease Vaccine Presentation

View